Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,272,645
-
Share change
-
+116,697
-
Total reported value
-
$61,858,654
-
Put/Call ratio
-
202%
-
Price per share
-
$4.33
-
Number of holders
-
62
-
Value change
-
+$791,275
-
Number of buys
-
26
-
Number of sells
-
24
Institutional Holders of ADAMAS PHARMACEUTICALS INC - COM (ADMS) as of Q4 2020
As of 31 Dec 2020,
ADAMAS PHARMACEUTICALS INC - COM (ADMS) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,272,645 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Opaleye Management Inc., MORGAN STANLEY, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, AIGH Capital Management LLC, Stonepine Capital Management, LLC, D. E. Shaw & Co., Inc., BlackRock Inc., and SILVERARC CAPITAL MANAGEMENT, LLC.
This page lists
62
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.